Author Correction: Engineering-enhanced CAR T cells for improved cancer therapy.

Milone, Michael C; Xu, Jie; Chen, Sai-Juan; Collins, McKensie A; Zhou, Jianfeng; Powell, Daniel J; Melenhorst, J Joseph

Milone, Michael C; Xu, Jie; Chen, Sai-Juan; Collins, McKensie A; Zhou, Jianfeng; Powell, Daniel J; Melenhorst, J Joseph.

Afiliação

Milone MC; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Xu J; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Chen SJ; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Collins MA; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Zhou J; Department of Hematology, Shanghai Institute of Hematology, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
Powell DJ; Department of Hematology, Shanghai Institute of Hematology, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
Melenhorst JJ; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Nat Cancer ; 2(10): 1113, 2021 10.

Article em En | MEDLINE | ID: mdl-35121886

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Idioma: En Revista: Nat Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google